Methodology

All entries for: Exousia AI

September 23, 2025

Exousia AI

Orphan Drug Designation

FDA orphan drug designation: treatment of malignant glioma

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top